Cordyceps Sunshine Biotech Holdings (RAJAF) Cash from Financing Activities (2022 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Cash from Financing Activities of $19171.0 in Q4 2023, down 33.75% quarter-over-quarter from $28938.0 in Q4 2022, and down 33.75% on a YoY basis from $28938.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) Cash from Financing Activities (2022 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $19171.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - -
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn -512.00 Mn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn -210.20 Mn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn -67.73 Mn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn -162.98 Mn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn 781.70 Mn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - -
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn -586.00 Mn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn -5.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 19,171.00
Dec 31, 2023 19,171.00
Dec 31, 2022 28,938.00
Dec 31, 2022 28,938.00